Treatment of hepatocellular carcinoma
- 1 February 2005
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Gastroenterology
- Vol. 19 (1) , 129-145
Abstract
No abstract availableKeywords
This publication has 106 references indexed in Scilit:
- Correlation Between Preoperative Serum Concentration of Type IV Collagen 7s Domain and Hepatic Failure Following Resection of Hepatocellular CarcinomaAnnals of Surgery, 2004
- Adjuvant Intra–Arterial Injection of Iodine–131-Labeled Lipiodol After Resection of Hepatocellular CarcinomaHepatology, 2003
- Percutaneous radiofrequency ablation of liver metastases in potential candidates for resectionCancer, 2003
- Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infectionCancer, 2003
- Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalHepatology, 2003
- Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trialThe Lancet, 2002
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJournal of Hepatology, 2001
- Hepatocellular carcinomaJournal of Hepatology, 2000
- EASL International Consensus Conference on Hepatitis C Paris, 26–28 February 1999Journal of Hepatology, 1999
- Genetic Aspects of Hepatocellular CarcinogenesisSeminars in Liver Disease, 1999